Alveolar macrophage deactivation in murine septic peritonitis: Role of interleukin 10

Infection and Immunity

Volumn 69, Issue 3, 2001, Pages 1394-1401

  Reddy, R C ^a   Chen, G H ^a   Newstead, M W ^a   Moore, T ^a   Zeng, X ^a   Tateda, K ^a   Standiford, T J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONITIS; PHAGOCYTOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; ASCITIC FLUID; BLOOD; CECUM; FEMALE; INTERLEUKIN-10; LIGATION; MACROPHAGES, ALVEOLAR; MICE; NEUTRALIZATION TESTS; PERITONITIS; PHAGOCYTOSIS; PUNCTURES; SEPSIS;

EID: 0035115013     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.3.1394-1401.2001     Document Type: Article

References (36)

1. Increased inducible apoptosis in CD4+ T lymphocytes during polymicrobial sepsis is mediated by Fas ligand and not endotoxin
2. Increased mucosal B-lymphocyte apoptosis during polymicrobial sepsis is a Fas ligand but not an endotoxin-mediated process
3. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model
4. Sepsis and its complications: The clinical problem
5. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis
6. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: Identification of interleukin-10 as a major functional deactivator of human monocytes
7. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units
8. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation
9. IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity
10. Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment
11. Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgery
12. Macrophages have cell surface IL-10 that regulates macrophage bactericidal activity
13. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
14. Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and gut by an endotoxin and TNF-independent pathway
15. Sepsis: Definitions and diagnosis
16. Regulation of neutrophil-derived chemokine expression by IL-10
17. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis
18. Interleukin-10 inhibits neutrophil phagocytic and bactericidal activity
19. Slow release of soluble TNF receptors by monocytes in vitro
20. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia
21. Interleukin-10 production during septicaemia
22. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS)
23. Interleukin-10
24. Dysregulation of in vitro cytokine production by monocytes during sepsis
25. Mechanism of endotoxin desensitization: Involvement of interleukin 10 and transforming growth factor beta
26. Delayed pulmonary clearance of gram-negative bacteria: The role of intraperitoneal sepsis
27. Lack of IL-10 synthesis by murine alveolar macrophages upon lipopolysaccharide exposure. Comparison with peritoneal macrophages
28. Anti-inflammatory cytokines and cytokine antagonists
29. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense
30. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2
31. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: Sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13
32. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production
33. Monocyte deactivation - Rationale for a new therapeutic strategy in sepsis
34. Balance of inflammatory cytokines related to severity and mortality of murine sepsis
35. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms
36. Sepsis-induced apoptosis of the thymocytes in mice